Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rhinitis medicamentosa: an increasing therapeutical problem]

S Betlejewski1

  • 1Katedra i Klinika Otolaryngologii AM w Bydgoszczy.

Otolaryngologia Polska = the Polish Otolaryngology
|January 1, 1997
PubMed
Summary

Topical decongestants, commonly prescribed for rhinitis, can cause rhinitis medicamentosa with prolonged use. This condition, characterized by nasal swelling and obstruction, poses a significant health risk, especially for neonates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of nasal trauma in children].

Otolaryngologia polska = The Polish otolaryngology·2002
Same author

Rhinospirography in evaluation of respiratory disorders in patients with central nervous system tumors.

Medical science monitor : international medical journal of experimental and clinical research·2001
Same author

[The influence of neck-dissection operations on cervical and cerebral blood circulation].

Otolaryngologia polska = The Polish otolaryngology·2000
Same author

[Osteochondroma of the larynx].

Otolaryngologia polska = The Polish otolaryngology·2000
Same author

Von Willebrand factor in plasma of patients with advanced stages of larynx cancer.

Thrombosis research·1999
Same author

[Physiology and surgery of the nose].

Otolaryngologia polska = The Polish otolaryngology·1998

Area of Science:

  • Otorhinolaryngology
  • Pharmacology

Context:

  • Rhinitis is a prevalent upper respiratory condition.
  • Topical decongestants are frequently prescribed by ENT specialists and general practitioners for rhinitis, irrespective of its cause.
  • Long-term application of topical vasoconstrictors can lead to adverse effects.

Purpose:

  • To highlight the risks associated with long-term use of topical decongestants.
  • To explain the pathophysiology of rhinitis medicamentosa.
  • To emphasize the critical need for prevention.

Summary:

  • Prolonged use of topical vasoconstrictors for rhinitis can induce rhinitis medicamentosa, a condition involving rebound nasal mucosal swelling.
  • This swelling may stem from vasodilatation or interstitial edema and can damage nasal cilia and epithelial cell mitochondria, impairing function.
  • Rhinitis medicamentosa resulting from vasoconstrictor abuse causes nasal obstruction, a potentially life-threatening issue in neonates.

Impact:

  • Rhinitis medicamentosa represents a growing therapeutic challenge.
  • Prevention strategies are crucial for managing this condition effectively.
  • Understanding the adverse effects of topical decongestants is vital for patient safety and optimal treatment outcomes.

Related Experiment Videos